Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesEndocrine, Nutritional and Metabolic Diseases and DisordersDRG 623-skin-grafts-and-wound-debridement-for-endocrine-nutritional-and-metabolic-disorders-with-cc
    Ask Trek AI about this page

    Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders with CC: Inpatient Reimbursement Overview

    DRG 623 includes inpatient stays for patients with endocrine, nutritional, or metabolic disorders who undergo wound debridement or skin grafting and have one or more Complications or Comorbidities, affecting clinical complexity and resource needs. Proper capture of diagnoses, procedures, and Complication or Comorbidity status matters for Medicare inpatient reimbursement because it determines grouping and payment under the prospective payment system.

    Customize your policy alerts

    Sign up for drg 623 policy alerts

    Get alerted when payer policies referencing 623 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 623 Overview

    DRG 623—Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders with Complication or Comorbidity—covers inpatient admissions where patients with endocrine, nutritional, or metabolic conditions require wound debridement and/or skin grafting and have at least one documented complication or comorbidity. This Diagnosis-Related Group groups cases with added clinical complexity that typically increase resource use, such as prolonged operating time, specialized wound care, and extended hospital stays. It matters for Medicare payment because the presence of a Complication or Comorbidity elevates the relative weight and prospective payment compared with cases without such comorbid conditions. Accurate coding of the underlying endocrine or metabolic diagnosis, the wound procedure, and any Complication or Comorbidity is essential to assign the proper Diagnosis-Related Group and corresponding inpatient reimbursement.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute surgical intervention trials evaluating novel debridement techniques or optimized surgical protocols for patients with endocrine, nutritional, and metabolic disorders (such as poorly controlled diabetes and severe malnutrition) who require skin grafting or extensive wound debridement. These studies typically enroll hospitalized adults with infected or non-healing lower-extremity ulcers, necrotizing soft tissue infections, or pressure injuries complicated by metabolic derangements, and compare operative timing, extent of debridement, or adjunct intraoperative methods to reduce tissue loss and operative complications. Results inform surgeons and hospital administrators about best practices to reduce intraoperative morbidity, length of stay, and immediate postoperative resource use for this high-risk DRG cohort.
    • Comparative effectiveness trials of perioperative and inpatient multidisciplinary management strategies (for example, standardized glycemic control pathways, infection prophylaxis bundles, nutrition optimization, and coordinated wound-care teams) in patients with endocrine, nutritional, or metabolic disorders undergoing skin grafting or debridement. These pragmatic studies enroll medically complex inpatients to compare bundled care versus usual care on outcomes such as graft take, wound healing, readmission rates, and inpatient costs. Findings are relevant to payers and providers because they identify care models that may decrease complications, shorten hospitalization, and reduce total cost of care for DRG 623 admissions.
    • Post-discharge and outcomes research following hospitalization for skin grafts and debridement in patients with metabolic disease, focusing on long-term wound recurrence, functional status, rehospitalization, and outpatient resource utilization. Cohort studies or registry-based analyses examine patients after discharge to assess factors like adherence to outpatient wound care, glycemic control, social determinants of health, and access to rehabilitation that predict readmission or chronic non-healing wounds. This research guides discharge planning, community-based interventions, and payment models by highlighting predictors of costly downstream utilization and opportunities for targeted transitional care to reduce future claims associated with this DRG.

    Related Codes

    614-ADRENAL-AND-PITUITARY-PROCEDURES-WITH-CC-MCC

    Adrenal and Pituitary Procedures with CC/MCC: Inpatient Reimbursement Overview

    615-ADRENAL-AND-PITUITARY-PROCEDURES-WITHOUT-CC-MCC

    Adrenal and Pituitary Procedures without CC/MCC: Inpatient Reimbursement Overview

    616-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-MCC

    Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders with MCC: Inpatient Reimbursement Overview

    617-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-CC

    Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders with CC: Inpatient Reimbursement Overview

    618-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITHOUT-CC-MCC

    Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders without CC/MCC: Inpatient Reimbursement Overview

    619-O-R-PROCEDURES-FOR-OBESITY-WITH-MCC

    O.R. Procedures for Obesity with MCC: Inpatient Reimbursement Overview

    620-O-R-PROCEDURES-FOR-OBESITY-WITH-CC

    O.R. Procedures for Obesity with CC: Inpatient Reimbursement Overview

    621-O-R-PROCEDURES-FOR-OBESITY-WITHOUT-CC-MCC

    O.R. Procedures for Obesity without CC/MCC: Inpatient Reimbursement Overview

    622-SKIN-GRAFTS-AND-WOUND-DEBRIDEMENT-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-MCC

    Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders with MCC: Inpatient Reimbursement Overview

    624-SKIN-GRAFTS-AND-WOUND-DEBRIDEMENT-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITHOUT-CC-MCC

    Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders without CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 25

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.